Debt Financing - Tallac Therapeutics
Investment Firm
Overview
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Announced Date
Aug 02, 2023
Funding Type
Debt Financing
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Horizon Technology Finance |
Round Details and Background
Tallac Therapeutics raised $5000000 on 2023-08-02 in Debt Financing
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 23, 2020 |  Venture Round - Tallac Therapeutics | - | 21.2M | |
| Dec 01, 2020 | Series A - Tallac Therapeutics | 5 | - | 62.0M |
| Aug 02, 2023 | Debt Financing - Tallac Therapeutics | 1 | - | 5.0M |
Recent Activity
There is no recent news or activity for this profile.